查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591730

醫療設備的軟體市場:現狀分析與預測(2024年～2032年)

Software as a Medical Device Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計預測期內（2024-2032 年），醫療設備軟體 (SaMD) 市場將實現約 10.71% 的顯著成長。隨著全球慢性病的盛行率和發生率逐年上升，迫切需要擴大SaMD等創新醫療解決方案的應用，以應對日益增長的疾病族群。 SaMD 將促進早期診斷並加強疾病監測過程，進一步協助醫療專業人員提供適當的疾病管理。例如，根據世界衛生組織（WHO）的數據，每年約有4,100萬人死於慢性疾病。高血壓、肥胖和高血糖等代謝危險因子是這一重點族群的主要死亡原因。為了應對日益增多的慢性病，​​世衛組織還建議注重預防措施，如早期發現、及時篩檢和有效的治療措施。

SaMD 具有提供準確、快速診斷的潛力，這是高效疾病管理過程的關鍵要素。這導致患者和醫療保健提供者對 SaMD 解決方案的需求不斷增加，從而帶動軟體即醫療設備市場顯著增長。

根據部署，市場分為雲端和本地。其中，基於雲端的服務由於其成本效益、高效的資料儲存容量以及可透過網路連接從任何地方存取的能力而佔據了很大的市場佔有率。

根據應用，市場分為診斷、監測和臨床管理。其中，疾病控制在全球範圍內佔有很大佔有率。推動成長的因素包括人口老化以及糖尿病、心血管疾病和癌症等慢性病盛行率的增加。 SaMD 在快速、高品質資料收集和改善醫療服務方面具有巨大潛力，從而增加了對用於疾病臨床管理的軟體即醫療設備解決方案的需求。

依治療領域，市場分為代謝、腫瘤學、呼吸學、心臟科、神經科學、血液學等。其中，腫瘤學領域的複合年增長率最高，這得益於癌症發病率的上升以及人們對癌症管理計劃中早期診斷重要性的認識的不斷提高。

為了更了解軟體作為醫療設備的市場採用情況，我們根據北美（美國、加拿大和北美其他地區）、歐洲（德國、法國、英國、西班牙、義大利和歐洲其他地區）、亞太地區（中國、日本、印度和亞太其他地區）和世界其他地區的全球影響力對市場進行了分析。北美佔據了軟體醫療器材市場的大部分佔有率，預計在預測期內將保持穩定的成長率。北美擁有強大的醫療保健基礎設施和採用新技術的能力，這帶動了 SaMD 市場的強勁投資和創新。此外，該地區也是 Imagen Technologies, Inc. 和 Digital Diagnostics Inc. 等主要製造商的所在地。鑑於巨大的生產量和對醫療保健解決方案的高需求，預計該地區將在預測期內主導醫療設備軟體市場的需求。

市場的主要參與者包括Siemens Healthineers, GE HealthCare Technologies Inc.，Koninklijke Philips N.V.，Aptar Digital Health，Qure.ai Technologies Private Limited，Imagen Technologies, Inc.，Digital Diagnostics Inc.，Viz.ai，HeartFlow, Inc.，Hologic, Inc.等。

目錄

第1章 市場簡介

  • 市場定義
  • 主要目的
  • 相關利益者
  • 限制事項

第2章 調查手法或前提條件

  • 調查流程
  • 調查手法
  • 受訪者簡介

第3章 摘要整理

  • 產業摘要
  • 各市場區隔預測
    • 市場成長的強度
  • 地區展望

第4章 市場動態

  • 促進因素
  • 機會
  • 阻礙因素
  • 趨勢
  • PESTEL分析
  • 需求面分析
  • 供給面分析
    • 合併和收購
    • 投資Scenario

第5章 全球醫療設備的軟體市場收益 , 2022-2032年

第6章 市場洞察:各部署

  • 雲端
  • 內部部署

第7章 市場洞察:各用途

  • 診斷
  • 監測
  • 臨床管理

第8章 市場洞察:各治療領域

  • 代謝
  • 腫瘤
  • 呼吸系統
  • 心臟血管
  • 神經科
  • 血液
  • 其他

第9章 市場洞察:各地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區

第10章 價值鏈分析

  • 主要零組件分析
  • 市場參與企業一覽

第11章 競爭情形

  • 競爭儀表板
  • 競爭市場定位分析
  • 波特的五力分析

第12章 企業簡介

  • Siemens Healthineers
    • Company Overview
    • Key Financials
    • SWOT Analysis
    • Product Portfolio
    • Recent Developments
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Aptar Digital Health Inc.
  • Qure.ai Technologies Private Limited
  • Imagen Technologies, Inc.
  • Digital Diagnostics Inc.
  • Viz.ai
  • HeartFlow, Inc.
  • Hologic, Inc.

第13章 縮寫與前提條件

第14章 附錄

簡介目錄
Product Code: UMHE213044

Software as a Medical Device (SaMD) refers to software designed for one or more medical purposes to operate independently, without being a part of any hardware medical device. SaMD applications include diagnosis, monitoring or management of health conditions. It operates on general-purpose computing platforms, which means it does not need to be integrated into a physical medical device to fulfill its medical role. It can run on various platforms, such as mobile applications and cloud-based systems, that further enhance accessibility and usability in healthcare settings.

The Software as a Medical Device Market is expected to grow at a significant rate of around 10.71% during the forecast period (2024-2032). With the increasing global prevalence and incidence of chronic diseases year by year, there is a huge need to increase the application of innovative medical solutions such as SaMD to cater to the need of this growing diseased population. SaMD facilitates early diagnosis and enhances disease monitoring process, which further assists the healthcare professionals in providing appropriate disease management. For instance, as per the World Health Organization (WHO), around 41 million people die each year due to chronic diseases. Metabolic risk factors such as increased blood pressure, obesity and hyperglycemia are the leading cause of death among this major population. To combat the growing chronic diseases, WHO has also suggested emphasis on preventive measures such as early detection, timely screening and effective treatment measures.

SaMD has the potential to provide accurate and rapid diagnosis, which is an important factor for efficient disease management process. This has increased the demand for SaMD solutions among healthcare providers as well as patients, leading to the tremendous growth of the software as a medical device market.

Based on deployment, the market is segmented into cloud and on-premises. Of these, cloud segment holds the major market share due to its cost-effectiveness, efficient data storage capacity and provision of accessibility from any location with internet facility.

Based on the application, the market is segmented into diagnostics, monitoring and clinical management. Of these, disease management has held the major market share across the globe. Some of the factors that have attributed to growth are growing aging population and increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases and cancer. SaMD has huge potential in providing rapid and quality data collection and improved healthcare delivery services, leading to higher demand for software as a medical device solution for the clinical management of the diseases.

Based on therapeutic area, the market is segmented into metabolic, oncology, respiratory, cardiovascular, neuroscience, hematology and others. Of these, the oncology segment has exhibited the highest CAGR, fueled by growing incidence of cancer and increased awareness regarding importance of early diagnosis in the cancer management plan.

For a better understanding of the market adoption of the software as a medical device, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America holds a significant share of the software as a medical device market and is anticipated to maintain a steady growth rate over the forecast period. North America, with a robust healthcare infrastructure, allows adoption of new technologies that leads to substantial investments and innovation in the SaMD market. Additionally, the region is home to some of the largest manufacturers, such as Imagen Technologies, Inc. and Digital Diagnostics Inc. Considering the vast volume of production, and the high demand for healthcare solutions, the region is further anticipated to dominate the demand for software as a medical device market in the forecast period.

Some of the major players operating in the market include Siemens Healthineers, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Aptar Digital Health, Qure.ai Technologies Private Limited, Imagen Technologies, Inc., Digital Diagnostics Inc., Viz.ai, HeartFlow, Inc., Hologic, Inc.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Software as a Medical Device Market
  • 2.2. Research Methodology of the Software as a Medical Device Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario

5.GLOBAL SOFTWARE AS A MEDICAL DEVICE MARKET REVENUE (USD MN), 2022-2032F

6.MARKET INSIGHTS BY DEPLOYMENT

  • 6.1. Cloud
  • 6.2. On-premises

7.MARKET INSIGHTS BY APPLICATION

  • 7.1. Diagnostics
  • 7.2. Monitoring
  • 7.3. Clinical Management

8.MARKET INSIGHTS BY THERAPEUTIC AREA

  • 8.1. Metabolic
  • 8.2. Oncology
  • 8.3. Respiratory
  • 8.4. Cardiovascular
  • 8.5. Neuroscience
  • 8.6. Hematology
  • 8.7. Others

9.MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10.VALUE CHAIN ANALYSIS

  • 10.1. Key Component Analysis
  • 10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

  • 11.1. Competition Dashboard
  • 11.2. Competitor Market Positioning Analysis
  • 11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

  • 12.1. Siemens Healthineers
    • 12.1.1. Company Overview
    • 12.1.2. Key Financials
    • 12.1.3. SWOT Analysis
    • 12.1.4. Product Portfolio
    • 12.1.5. Recent Developments
  • 12.2. GE HealthCare Technologies Inc.
  • 12.3. Koninklijke Philips N.V.
  • 12.4. Aptar Digital Health Inc.
  • 12.5. Qure.ai Technologies Private Limited
  • 12.6. Imagen Technologies, Inc.
  • 12.7. Digital Diagnostics Inc.
  • 12.8. Viz.ai
  • 12.9. HeartFlow, Inc.
  • 12.10. Hologic, Inc.

13.ACRONYMS & ASSUMPTION

14.ANNEXURE